Chugai allots S$200 million for Singapore R&D research

New investment will be spent over five years to develop innovative drugs "to serve unmet medical needs".

Minister Lim Hng Kiang confirmed the fresh funds in a speech marking the opening of Chugai's Singapore R&D research centre, Singapore’s first corporate laboratory in the area of antibody engineering, .

"Following Chugai’s first research centre in Singapore, Chugai Pharmabody Research will build on Chugai’s existing R&D success by focusing on antibody research. In this regard, I am heartened to note that Chugai will be investing close to S$200 million over the next five years to developing and making innovative drugs at the facility to serve unmet medical needs," the minister said.

"We therefore welcome Chugai Pharmabody Research to form new partnerships within the clinical and research community here and leverage our diverse R&D talent, capabilities and expertise to translate research into quality healthcare solutions," he added.

The minister said that the government for its part, is keen on investing in biomedical sciences research to attract more companies like Chugai to undertake cutting-edge work in Singapore.

"Between year 2011 and 2015, we will invest $3.7 billion in biomedical sciences research. This is a 12 per cent increase from the preceding five years. Our investments will help pave the way for the biomedical research community in Singapore to engage meaningfully in industry-relevant research collaborations. In addition, it will enable them to stay at the forefront of science," he said.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia